<html>
<head>PUBMED IDs for MCH6</head>
<body bgcolor='#C5F0F2'><h1>MCH6</h1><a href='https://pubmed.ncbi.nlm.nih.gov/11094080/'>Dissection of Ras-dependent signaling pathways controlling aggressive tumor growth of human fibrosarcoma cells: evidence for a potential novel pathway.</a> November 30  2000<br><a href='https://pubmed.ncbi.nlm.nih.gov/11400345/'>Paired human fibrosarcoma cell lines that possess or lack endogenous mutant N-ras alleles as experimental model for Ras signaling pathways.</a> June 13  2001<br><a href='https://pubmed.ncbi.nlm.nih.gov/11400343/'>Recombinant adenoviral expression of dominant-negative Ras N17 blocking radiation-induced activation of mitogen-activated protein kinase pathway.</a> June 13  2001<br><a href='https://pubmed.ncbi.nlm.nih.gov/11400340/'>Induction of senescence by oncogenic Ras.</a> June 13  2001<br><a href='https://pubmed.ncbi.nlm.nih.gov/11400337/'>Analyses of TC21/R-Ras2 signaling and biological activity.</a> June 13  2001<br><a href='https://pubmed.ncbi.nlm.nih.gov/11400328/'>Ras regulation of urokinase-type plasminogen activator.</a> June 13  2001<br><a href='https://pubmed.ncbi.nlm.nih.gov/17455170/'>The secretory leukocyte protease inhibitor (SLPI) suppresses cancer cell invasion but promotes blood-borne metastasis via an invasion-independent pathway.</a> April 25  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/19342157/'>PI3K/Akt activity has variable cell-specific effects on expression of HIF target genes, CA9 and VEGF, in human cancer cell lines.</a> August 1  2009<br></body></html>
